DOCSLIB.ORG

Heavy Menstrual Bleeding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Heavy Menstrual Bleeding 25/06/2018 Definition • Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss which interferes with a woman's physical, social, emotional and/or material quality of life. Heavy Menstrual Bleeding (HMB): Replaced ‘menorrhagia’ Objective definition of HMB >80mL/ cycle or duration of >7 days Causes and Management • It can occur alone or in combination with other symptoms (e.g. intermenstrual bleeding, pelvic pain, pressure symptoms) Dr. William (Wee-Liak) Hoo, MD MRCOG Consultant Gynaecologist Prevalence King’s College Hospital NHS FT • The prevalence of HMB in objective studies (9 to 14%) and subjective studies 20 to 52%) in studies based on subjective assessment. • In the UK, almost 1.5 million women consult their General Practitioners UKCPA Women’s Health Group Masterclass (GPs) each year with menstrual complaints and the annual treatment cost Friday 22nd June 2018 exceeds £65 million. Causes • Uterine: Uterine fibroids (dysmenorrhoea, palpable mass, pressure symptoms) Adenomyosis (dysmenorrhoea, subfertility) Endometrial polyps (intermenstrual bleeding) Pelvic inflammatory disease (PID)/ infection (vaginal discharge, pelvic pain, intermenstrual and postcoital bleeding and pyrexia) Malignancy or atypical hyperplasia (irregular/ postcoital/ intermenstrual bleeding, pelvic pain, weight loss). • Ovarian: Polycystic ovary syndrome (acne, hursuitism) • Systemic diseases: Hypothyroidism (fatigue, constipation, cold intolerance and hair and skin changes) Coagulation disorders (e.g. von Willebrand disease) Liver or renal disease • Iatrogenic Anticoagulant treatment (warfarin, heparin) Copper Intrauterine Devices (IUD) Herbal supplements (e.g. ginseng, ginkgo and soya) — alters oestrogen levels or coagulation parameters Assessment • Taking a detailed clinical history. nature of the bleeding, impact on the woman's quality of life, Other factors which may affect treatment options (fertility, comorbidities, previous treatments?) IMB, PCB, pressure symptoms Previous treatments • Physical examination General & abdominal examination Pelvic and speculum examination +/- swabs (for infection) • Investigation: Full blood count for all women with HMB. Additional tests where appropriate e.g. coagulation screening, thyroid function testing. Ultrasound assessment – transvaginal +/- abdominal Outpatient Hysteroscopy Consider endometrial biopsy for women: Age >45 Persistent intermenstrual or irregular bleeding Infrequent heavy bleeding who are obese or have polycystic ovary UTERINE FIBROIDS syndrome Previous unsuccessful treatment (LEIOMYOMAS) 1 25/06/2018 ADENOMYOSIS • Definition - a benign condition of the uterus defined by the presence of endometrial glands and stroma within the myometrium. • Until recently, diagnosis was histological (post hysterectomy) = difficulties in assessing prevalence and clinical significance lack of clear and uniform histological criteria • Transvaginal ultrasound (TVS) and magnetic resonance • Fibroid growth is variable (vs. linear) - 18 to 120% per year imaging (MRI) shown to have high levels of accuracy in the pre-operative diagnosis of adenomyosis. • Fibroids undergo spontaneous regression, growth and shrinkage spurts outside of TVS well tolerated, inexpensive and widely available menopause • Overall prevalence of adenomyosis was 20.9% • Factors that influences growth rates: Increased with age, peaks at 32% in 40–49yo. Fibroid size at presentation - no agreement as to whether smaller or larger fibroids grew faster. • Women with ultrasound features of adenomyosis was Submucous fibroids were least likely to increase in size significantly more likely to have severe menstrual pain A reduction in growth rates with increasing age – only in black women • The endometrial–myometrial junction (EMJ) is thought to play an important role in both physiological and pathophysiological processes within the uterus. High resolution ultrasound assessment equipment with three- dimensional (3D) imaging facilities is often required • Ultrasound features of adenomyosis include: Management [NG88] asymmetrical myometrial thickening, • Consider starting pharmacological treatment for HMB without myometrial cysts, investigating the cause if the woman's history and/or examination suggests a low risk of fibroids, uterine cavity abnormality, histological linear striations, abnormality or adenomyosis. parallel shadowing, adenomyomas, • In women with no identified pathology, fibroids <3 cm or hyperechoic islands adenomyosis an irregular EMJ on B-mode or 3D imaging Pharmacological Treatments LNG-IUS(first treatment) non-hormonal: tranexamic acid NSAIDs hormonal combined hormonal contraception cyclical oral progestogens progesterone only contraception Surgical Option 2nd generation endometrial ablation Trancervical resection for submucous fibroids Hysterectomy 2 25/06/2018 Management Pharmacological • Levonorgestrel-releasing intrauterine system (LNG IUS) • In women fibroids >3 cm LNG released at 20 mg/ day – exerting local effects (thinning and atrophy of endometrium) Esmya (Ullipristal acetate) Reduces menstrual loss by up to 95% after 1 year, full benefit may not be seen in the first 6 months – temporary safety measure! Very little systemic absorption of the hormone Anyone on Esmya - monthly liver function testing SE: breast tenderness, headache, acne, erratic bleeding (esp. first 6 months) Do not start any new courses of Esmya, even if it was used safely • Tranexamic Acid: before. Antifibrinolytic, reducing menstrual blood loss by 58% Uterine artery embolization SE: indigestion, diarrhoea or headache (rare) CI: history of venous or arterial thromboembolism, renal impairment Surgical (including pre-treatment with a gonadotrophin- Cochrane review – more effective than NSAIDS, lutueal phase progesterone and placebo releasing hormone analogue) Myomectomy • Non-steroidal anti-inflammatory drugs (NSAIDs): Prostaglandin synthetase inhibitors Hysterectomy Mefenamic acid most frequently used, reduces blood loss by approximately 25%. SE: inhibits ovulation, indigestion, diarrhoea, aggravates asthma and peptic ulcer disease. Cochrane review – more effective than placebo but less than tranexamic or LNG IUS. • Combined oral contraceptive pill Reduction of menstrual loss of 43%. SE: nausea, mood changes, breast tenderness and VTE (esp. smokers, ↑BMI and ↑ age). • Progestogens Cyclical - Norethisterone acetate (5 mg, TDS – taken from day 5 to 26) reduces HMB SE: weight gain, bloating, breast tenderness, headache, acne and depression. Endometrial Ablation Uterine Artery Embolization • Endometrial ablation is targeted destruction of endometrium. • Procedure • Second generation techniques fluid filled • Interventional Radiology (IR) – LA/ sedation thermal balloon ablation and impedance • MRI assessment controlled endometrial ablation. • Percutaneous catheter Day cases • Embolisation of uterine arteries Pre ablation endometrial histology should be • Collaterals – ovarian and vaginal arteries obtained Advised to use effective contraception • Advantages • Shorter waiting times • Ideally: • No general anesthesia Uterus no bigger than 10 weeks pregnancy size • Shorter recovery Smaller fibroids <3cm • Lower total cost Family must be complete • Disadvantages / Side-Effects • Post operatively: • Post-embolization syndrome transient crampy abdominal pain and • Serious complications – sepsis watery brown discharge (3 - 4 weeks) • Fertility – Miscarriage rate, POI • 20% re-intervention rate • Outcome 1/3 amenorrhoeic, 1/3 markedly reduced menstrual loss and 1/3 no difference Hysteroscopic Resection Myomectomy - Surgical Approach FIGO stage Approach Comments L 0-1 Hysteroscopic Fluid overload L 2-8 Laparoscopic or Selection criteria for Open Laparoscopic Uterine size Number of fibroids Total volume of fibroids Number of uterine incision Multiple Combined or Open surgery • GnRH agonist – 3 months before surgery • Risks: bleeding, transfusion, infection, hysterectomy 3 25/06/2018 FDA Safety Alerts (2014, 2017) Fibroid Uterus Cavity Questions? 4.
Load more

Recommended publications
  • Management of Adenomyosis a Review of Characteristic Imaging Findings and Treatment Options, with an Emphasis on the Use of Uterine Artery Embolization
    WOMEN’S HEALTH Management of Adenomyosis A review of characteristic imaging findings and treatment options, with an emphasis on the use of uterine artery embolization. BY THERESA M. CARIDI, MD, AND JAMES B. SPIES, MD, MPH denomyosis is defined as ectopic endometrial tis- myosis on MRI include thickening of the junctional sue within the musculature of the uterus.1 It is a zone exceeding 12 mm and high-signal-intensity foci challenging condition in that it often overlaps in on T2/T1-weighted images similar to the case shown in symptoms and is found in conjunction with other Figure 1.4 Many studies have evaluated the diagnostic Agynecologic disorders, including endometriosis and uterine accuracy of TVUS and MRI techniques for adenomyosis. leiomyoma (fibroids).2 The typical clinical manifestations TVUS has a sensitivity of approximately 72% and speci- of adenomyosis occur in women who are 40 to 50 years of ficity of 81% versus 77% and 89% for MRI, respectively.8 age and include abnormal uterine bleeding and dysmenor- In addition, MRI can provide greater detail about the rhea (65% of patients).1 The exact pathogenesis is not fully extent of disease and additional uterine lesions, as well defined but is thought to be the result of direct invagina- as information about the less common presentation of tion of the endometrium into the myometrium.3 The adenomyosis, where focal disease in the form of an ade- interventionalist’s role is to offer uterine artery emboliza- nomyoma is present rather than the more typical diffuse tion (UAE), which provides some benefits over traditional adenomyosis findings.
    [Show full text]
  • Sonography of Adenomyosis
    3105jumonline.qxp:Layout 1 4/19/12 9:48 AM Page 805 SOUND JUDGMENT SERIES Sonography of Adenomyosis Khaled Sakhel, MD, Alfred Abuhamad, MD Invited paper denomyosis was first described by Rokitansky in 1860 as “cystosarcoma adenoides uterinum” and was later defined A by Von Recklinghausen in 1896. It is a common condition that predominantly affects women in the late reproductive years. Adenomyosis has been noted to occur in about 30% of the general female population and in up to 70% of hysterectomy specimens depending on the definition of the entity.1 The diagnosis can be The Sound Judgment Series consists of made with sonography or magnetic resonance imaging (MRI), but invited articles highlighting the clinical this article will show that sonography should be the imaging modal- value of using ultrasound first in specific ity of choice for adenomyosis. clinical diagnoses where ultrasound has Definition shown comparative or superior value. The series is meant to serve as an educational Adenomyosis is defined by the presence of ectopic endometrial tool for medical and sonography students glands and stroma within the myometrium. The presence of ectopic and clinical practitioners and may help endometrial glands and stroma induces a hypertrophic and hyper- integrate ultrasound into clinical practice. plastic reaction in the surrounding myometrial tissue. Clinical Presentation Most patients with adenomyosis are asymptomatic. Symptoms related to adenomyosis include dysmenorrhea, dyspareunia, chronic pelvic pain, and menstrual menometrorrhagia. Adeno- myosis presents most commonly as a diffuse disease involving the entire myometrium (Figure 1). It can also present in a focal area of the uterus, known as adenomyoma (Figure 2).
    [Show full text]
  • Chronic Vulvar Irritation, Itching, and Pain. What Is the Diagnosis?
    SECOND OF 2 PARTS ON OFFICE MANAGEMENT OF BENIGN VULVAR CONDITIONS Chronic vulvar irritation, itching, and pain. What is the diagnosis? Five cases of dermatoses, vaginal abnormalities, and pain syndromes that may masquerade as infection Libby Edwards, MD, and Beth E. Goldbaum, MD hronic irritation, itching, and pain CASE 1 Introital burning and a fear are only rarely due to infection. of breast cancer C These symptoms are more likely to A 56-year-old woman visits your office for be caused by dermatoses, vaginal abnormali- management of recent-onset introital burn- ties, and pain syndromes that may be difficult ing during sexual activity. She reports that to diagnose. Careful evaluation should in- her commercial lubricant causes irritation. clude a wet mount and culture to eliminate Topical and oral antifungal therapies have not infection as a cause so that the correct diag- been beneficial. She has a strong family his- IN THIS nosis can be ascertained and treated. tory of breast cancer. ARTICLE In Part 2 of this two-part series, we focus On examination, she exhibits small, When a woman on five cases of vulvar dermatologic disrup- smooth labia minora and experiences pain is reluctant to use tions: when a cotton swab is pressed against the local estrogen • atrophic vagina vestibule. The vagina is also smooth, with page 32 • irritant and allergic contact dermatitis scant secretions. Microscopically, these • complex vulvar aphthosis secretions are almost acellular, with no • desquamative inflammatory vaginitis increase in white blood cells and no clue A teenager • inverse psoriasis. cells, yeast forms, or lactobacilli. The pH is with vulvar pain greater than 6.5, and most epithelial cells are and sores parabasal (FIGURE 1, page 32).
    [Show full text]
  • Managing Infertility When Adenomyosis and Endometriosis Co-Exist
    Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China 27th April 2018 • IPSEN symposium Endometriosis • Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects mainly reproductive-age women • Endometriosis is considered to be responsible for infertility and pelvic pain • May affect 10% of women of reproductive age • Three types of pelvic endometriosis • Peritoneal Endometriosis • Ovarian Endometrioma • Deeply Infiltrating Endometriosis (DIE) 27th April 2018 • IPSEN symposium Adenomyosis • Adenomyosis (AD) is defined by the presence of endometrial glands and stroma in the myometrium • Prevalence: varies significantly between studies (from 5% to 70%), generally underestimated • Most frequent symptoms: dysmenorrhea, abnormal uterine bleeding, etc. • Two types: diffuse form, focal form 27th April 2018 • IPSEN symposium PEM DIE OEM AD+EM 27th April 2018 • IPSEN symposium Macroscopic and microscopic appearance of AD 27th April 2018 • IPSEN symposium MRI Features of AD—focal and diffuse 27th April 2018 • IPSEN symposium Prevalence of EM in patients with AD Adenomyosis Endometriosis Author N N(%) Leng JH et al.(2011) 72(histology) 24(33.3%) Di Donato et al. (2014) 217(ultrasound) 165(76.0%) Chapron et al. (2017) 175(MRI) 153(87.4%) Leyendecker et al. (2015) 67(MRI) 54(80.6%) Em and AD often coexist Several authors reported the prevalence of EM in patients with AD. Our study showed in 72 histologically diagnosed AD, 33.3% had concomitant EM. Chapron and another 2 authors reported in US/MRI diagnosed AD, 76-87% had coexistant EM 27th April 2018 • IPSEN symposium What is the relationship between endometriosis phenotypes and adenomyosis? EM subtype N Diffuse form Focal form PEM 40 8(20.0%) 3(7.5%) OEM 31 14(45.2%) 6(19.3%) DIE 166 59(35.5%) 110(66.3%) • Surgery findings of 175 preoperatively MRI diagnosed AD and histologically diagnosed of EM • Among EM women, diffuse AD had no correlation with EM phenotypes.
    [Show full text]
  • Adenomyosis and Infertility
    Reproductive BioMedicine Online (2012) 24,35– 46 www.sciencedirect.com www.rbmonline.com REVIEW Adenomyosis and infertility Sebastiano Campo a, Vincenzo Campo a,*, Giuseppe Benagiano b a Institute of Obstetrics and Gynaecology, Catholic University of Sacred Heart, Rome, Italy; b Department of Obstetrics, Gynaecology and Urology, Sapienza, University of Rome, Rome, Italy * Corresponding author. E-mail address: [email protected] (V Campo). Prof Sebastiano Campo has been associate professor in the Department of Obstetrics and Gynecology at the Catholic University of the Sacred Heart in Rome since 1984. His special interests include ovarian physiology, infertility, endometriosis and polycystic ovary syndrome. Abstract Today an accurate diagnosis of adenomyosis can be made thanks to progress in imaging techniques: sonography and mag- netic resonance imaging (MRI). This has made it possible to clinically correlate the presence of adenomyosis to infertility. At the same time, a series of pathogenetic hypotheses have been presented to explain this correlation. First, the identification of the myo- metrial junctional zone (JZ) and of its disruption and thickening has been linked to poor reproductive performance mainly through perturbed uterine peristalsis, a phenomenon that originates exclusively from the JZ in the nonpregnant uterus. In addition, a number of biochemical and functional alterations in both eutopic and heterotopic endometrium in women with adenomyosis have now been found to lead to lower receptivity, indicated by the presence of ‘implantation marker’ defects. In these patients there is also an altered decidualization and abnormal concentrations of intrauterine free radicals. All these abnormalities in the endometrial envi- ronment seem to contribute to subfertility. Several attempts have been made to restore fertility in adenomyosis patients, the oldest being gonadotrophin-releasing hormone agonists coupled to conservative surgery.
    [Show full text]
  • ABNORMAL UTERINE BLEEDING Randomized Data Shed Light on AUB Associated with Fibroids, Adenomyosis, and the Use of Progestins
    UPDATE ABNORMAL UTERINE BLEEDING Randomized data shed light on AUB associated with fibroids, adenomyosis, and the use of progestins ›› Malcolm G. Munro, MD Dr. Munro is Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA and Director of Gynecologic Services at Kaiser Permanente, Los Angeles Medical Center, in Los Angeles, California. Dr. Munro reports that he is a consultant to Bayer HealthCare. s recently defined by the International • Coagulopathy AFederation of Gynecology and Obstet- • Ovulatory disorders rics (FIGO)—and endorsed by the American • Endometrial dysfunction College of Obstetricians and Gynecologists— • Iatrogenic the term “abnormal uterine bleeding” (AUB) • Not otherwise classified. IN THIS ARTICLE now describes any departure from normal A given individual may be found to have one menstrual bleeding.1 To determine the most or more of these features, but not all of the Consider the appropriate intervention for this widespread features may contribute to the AUB. To facili- levonorgestrel- problem, FIGO proposed that clinicians con- tate their use, these nine causes are more releasing sider potential contributors to the clinical commonly identified using the acronym intrauterine system problem by investigating and categorizing PALM-COEIN. for AUB related to patients according to the following system: In this article, I focus on three of these adenomyosis • Polyp categories, presenting recent data on AUB • Adenomyosis associated with leiomyomata (AUB-L) or ade- page 30 • Leiomyoma nomyosis (AUB-A), and AUB of an iatrogenic • Malignancy and hyperplasia nature (AUB-I). For AUB associated with the use of progestins, concomitant AUB-L: Satisfaction rates are similar doxycycline may be of benefit 5 years after fibroid treatment by page 31 surgery or uterine artery embolization Gupta JK, Sinha A, Lumsden MA, Hickey M.
    [Show full text]
  • Choose to Be Informed About Chronic Pelvic Pain Conditions
    Choose to Be Informed About ChronicPreparing Pelvic Painfor SurgeryConditions | | 3 1 Choose to Be Informed About Chronic Pelvic Pain Conditions. Pelvic Pain Conditions 2 Women’s Services at Every Age and Stage of Life 5 Screenings You Need 6 – 7 Your Medical History 8 – 10 Family History 11 – 12 My Physicians 13 Choose to Be Informed About ChronicPreparing Pelvic Painfor SurgeryConditions | | 3 2 Gynecological issues involving the pelvic area affect many women during their lifetime. Chronic pelvic pain is pain located between the stomach and hips that lasts for six months or longer. For women, there can be many different causes of pelvic pain. This guide explains the most common types of female pelvic conditions and what can be done to treat them. Abnormal Uterine Bleeding Painful Periods Abnormal uterine bleeding is defined as bleeding that Painful menstrual periods, also called dysmenorrhea, occurs between periods, or is heavier or lasts longer are the leading cause of lost time from school and than normal. Menstrual cycles that are longer than 35 work among women in their teens and 20s. Painful days or shorter than 21 days are considered abnormal. periods may include pain in the pelvis, abdomen, Bleeding that occurs after intercourse or any time after back and legs; abdominal cramps; headache; and menopause is also abnormal. fatigue. There are many possible causes of abnormal uterine There are two types of dysmenorrhea. Primary bleeding, including fibroids, polyps, infection dysmenorrhea is caused by high levels of or cancer of the uterus or cervix, polycystic prostaglandins — hormone-like substances — in the ovary syndrome (an endocrine system disorder), uterus.
    [Show full text]
  • Pregnancy Outcomes of Infertile Women with Co- Existing Endometriosis and Adenomyosis After Laparoscopic Surgery: a Long-Term Follow-Up
    Pregnancy outcomes of infertile women with co- existing endometriosis and adenomyosis after laparoscopic surgery: a long-term follow-up Jinghua Shi Peking Union Medical College Hospital https://orcid.org/0000-0001-5267-9092 Yi Dai Peking Union Medical College Hospital Junji Zhang Peking Union Medical College Hospital Xiaoyan Li Peking Union Medical College Hospital Shuangzhen Jia Peking Union Medical College Hospital Jinhua Leng ( [email protected] ) Peking Union Medical College Hospital Research article Keywords: Adenomyosis, Endometriosis; Infertility, Laparoscopic surgery, Pregnancy outcome Posted Date: October 6th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-85435/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Background: Adenomyosis and endometriosis are often co-existent. Laparoscopic surgery is one of the main methods to diagnose and treat these conditions. However, very few studies have been done that concentrate on the pregnancy outcomes of infertile women with both adenomyosis and endometriosis after laparoscopic surgery, as well as the relevant inuential factors. Methods: This is a retrospective, cross-sectional study including infertile women diagnosed with endometriosis and adenomyosis. All patients had undergone laparoscopic surgery and were divided into two groups according to pregnancy outcomes. Demographic data, operation records, and pregnancy outcomes were collected. Results: Ninety-seven patients had live births, including 81 full-term and 16 preterm deliveries. The biochemical pregnancy, clinical pregnancy, and live birth rates were 80.87%, 67.4, and 55.11% respectively. One hundred thirty-ve patients received IVF with 70 (51.85%) patients having live births.
    [Show full text]
  • ACR Appropriateness Criteria: Abnormal Uterine Bleeding
    Revised 2020 American College of Radiology ACR Appropriateness Criteria® Abnormal Uterine Bleeding Variant 1: Abnormal uterine bleeding. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US duplex Doppler pelvis Usually Appropriate O US pelvis transabdominal Usually Appropriate O US pelvis transvaginal Usually Appropriate O US sonohysterography May Be Appropriate (Disagreement) O MRI pelvis without and with IV contrast Usually Not Appropriate O MRI pelvis without IV contrast Usually Not Appropriate O CT pelvis with IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢ Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed. Procedure Appropriateness Category Relative Radiation Level US sonohysterography Usually Appropriate O MRI pelvis without and with IV contrast Usually Appropriate O US duplex Doppler pelvis May Be Appropriate (Disagreement) O US pelvis transabdominal May Be Appropriate (Disagreement) O US pelvis transvaginal May Be Appropriate (Disagreement) O MRI pelvis without IV contrast May Be Appropriate (Disagreement) O CT pelvis with IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢ ACR Appropriateness Criteria® 1 Abnormal Uterine Bleeding Variant 3: Abnormal uterine bleeding. Follow-up imaging
    [Show full text]
  • Dyspareunia: 5 Overlooked Causes
    OBGMANAGEMENT ■ BY ELIZABETH G. STEWART, MD Dyspareunia: 5 overlooked causes Disorders ranging from a simple anatomic problem to a complex psychosocial/ biologic phenomenon can cause difficult or painful coitus. An expert outlines diagnosis and treatment strategies for 5 common causes and offers guidance on how to conduct the physical exam and elicit information from the patient. dentifying the cause of a patient’s dyspare- pareunia can present a significant challenge unia can be just as challenging as getting to clinicians. Adding to the difficulty is the I her to admit to the problem. fact that intermittent conditions such as cycli- Due in part to underreporting of the con- cal Candida albicans are hard to diagnose. dition, the incidence and prevalence of dys- This review of 5 common but often over- pareunia—defined as genital pain experi- looked causes describes what is known about enced just before, during, or after sexual inter- dyspareunia and how to conduct a complete course1—is uncertain.2 evaluation, including physical examination, Because it is easy to miss subtle physical diagnostic tests, and questions to ask the patient. findings such as small fissures, periclitoral scarring, or a focus of tender vestibulitis under ■ CAUSE 1 a hymenal remnant, getting to the root of dys- Inadequate estrogenization Vulvovaginal atrophy is the leading cause of KEY POINTS sexual dysfunction, affecting up to 50% of ■ The leading cause of dyspareunia for women women over age 50. It contributes to a lack of under age 50 is vulvar vestibulitis; for women over vaginal lubrication with sexual arousal and, age 50, it is vulvovaginal atrophy.
    [Show full text]
  • National Institute for Health and Care Excellence
    IP 1065 [IPGXXX] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of uterine artery embolisation for treating adenomyosis Treating adenomyosis by blocking the blood supply to affected parts of the uterus Adenomyosis is a condition where some of the lining tissue of the womb grows into its outer muscular layer: this can cause heavy and painful menstrual periods. Uterine artery embolisation involves injecting small particles into the blood vessels that take blood to the uterus, via arteries in the groin. The aim is to block the blood supply to the adenomyosis so that it shrinks, which may then relieve the symptoms. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this overview to help members of the Interventional Procedures Advisory Committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This overview was prepared in April 2013. Procedure name Uterine artery embolisation for treating adenomyosis Specialist societies British Society of Interventional Radiology Royal College of Obstetricians and Gynaecologists Royal College of Radiologists IP overview: uterine artery embolisation for treating adenomyosis Page 1 of 33 IP 1065 [IPGXXX] Description Indications and current treatment Adenomyosis is a benign condition characterised by presence of ectopic endometrial glands and stroma within the myometrium. Adenomyosis frequently occurs coincidentally with fibroids. Adenomyosis may cause no symptoms but some women with adenomyosis experience heavy, prolonged menstrual bleeding with severe cramps, pelvic pain and discomfort.
    [Show full text]
  • Heavy Menstrual Bleeding
    Heavy Menstrual Bleeding Normal Periods A woman normally loses between 30 and 40ml of blood with her period (six to eight teaspoonfuls) each month but there is much variability. Bleeding can last up to eight days, but bleeding for five days is average. Heavy Menstrual Bleeding There are medical definitions of heavy menstrual bleeding, but the only practical definition is when there is excessive menstrual blood loss that interferes with the physical, emotional, social and material quality of life. Monthly periods are an individual experience and women who have always had heavy periods will consider this normal. However if you believe that your periods are either unusually heavy, prolonged or both, there are many different Figure 1. Female reproductive anatomy treatment options available to you. You may or may not have some of Uterine-related problems the following problems: 1. The uterus can have abnormalities in the muscle of the uterus wall that prevents the uterus from squeezing and contracting • Losing more than 5– 6 tablespoons of blood (80mls) well and hence allow blood vessels to continue to bleed • Passing clots that are larger than a 50 cent coin • Bleeding so much that you have to change your pad/tampon 2. Fibroids are benign non-cancerous growths in the muscle every hour of the uterus. Fibroids can cause heavy menstrual bleeding, • Having to get up most nights to change your pad/tampon pelvic pressure or pain and problems with fertility and • Having to put a towel in your bed or use large maternity pads pregnancy. However, fibroid symptoms tend to get better when you sleep after menopause.
    [Show full text]